Duearity (DB:9DS) - Stock Price, News & Analysis

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

9DS Stock Overview

A medical technology company, engages in the development and production of solutions for tinnitus.

About the company

9DS fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Negative shareholders equity

Does not have a meaningful market cap (€3M)

Has less than 1 year of cash runway

Shareholders have been substantially diluted in the past year

+ 3 more risks

Duearity AB (publ) Competitors

MagForce

DB:MF6

€366.9k

MagForce

XTRA:MF6

€3.6m

Audientes

DB:AUG

€6.9m

aap Implantate

XTRA:AAQ1

€22.2m

Price History & Performance

Summary of all time highs, changes and price drops for Duearity
Historical stock prices
Current Share Price	SEK 0.0012
52 Week High	SEK 0.35
52 Week Low	SEK 0.0011
Beta	1.8
11 Month Change	-79.66%
3 Month Change	-75.00%
1 Year Change	-99.66%
33 Year Change	-99.84%
5 Year Change	n/a
Change since IPO	-99.77%

Recent updates

Shareholder Returns

	9DS	DE Medical Equipment	DE Market
7D	9.1%	4.6%	-1.4%
1Y	-99.7%	0.4%	11.8%

Return vs Industry: 9DS underperformed the German Medical Equipment industry which returned 5.5% over the past year.

Return vs Market: 9DS underperformed the German Market which returned 4.2% over the past year.

Price Volatility

Is 9DS's price volatile compared to industry and market?
9DS volatility
9DS Average Weekly Movement	77.6%
Medical Equipment Industry Average Movement	5.3%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	11.6%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 9DS's share price has been volatile over the past 3 months.

Volatility Over Time: 9DS's weekly volatility has increased from 46% to 78% over the past year.

About the Company

Founded	Employees	CEO	Website
2020	2	Fredrik Westman	www.duearity.com

Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help people predict the symptoms and manage their problems. The company was incorporated in 2020 and is based in Malmö, Sweden.

Duearity AB (publ) Fundamentals Summary

How do Duearity's earnings and revenue compare to its market cap?
9DS fundamental statistics
Market cap	€270.18k
Earnings (TTM)	-€2.60m
Revenue (TTM)	€143.55k

1.9x

P/S Ratio

-0.1x

P/E Ratio

Is 9DS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
9DS income statement (TTM)
Revenue	SEK 1.64m
Cost of Revenue	SEK 2.71m
Gross Profit	-SEK 1.07m
Other Expenses	SEK 28.64m
Earnings	-SEK 29.70m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.15
Gross Margin	-65.04%
Net Profit Margin	-1,812.26%
Debt/Equity Ratio	-100.3%

How did 9DS perform over the long term?

See historical performance and comparison

Duearity DB:9DS Stock Report